BridgeMD
New treatment option for Gut Microbiota
Official title MiCrobiota-gut-brain Axis in Resistant Epilepsy
ClinicalTrials.gov ID: NCT07010445
What this study is testing
What is anti-epileptic drugs;?
anti-epileptic drugs; is an investigational medicine, being studied as a potential treatment for gut microbiota.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Epilepsy is one of the most common neurological chronic conditions with a serious burden on patients, their caregivers, and society. Drug-resistant epilepsy (DRE) heightens this burden.
- Time commitment: about 15 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 3 to 50
You may be able to join if
- 3-50 years old;
- diagnosis of epilepsy at onset or DRE;
- ensured participation of the patient or a caregiver;
- willingness to sign the informed consent.
You likely can't join if
- diagnosis of organic gastrointestinal disorders (e.g. chronic inflammatory bowel disease);
- special diets;
- use of antibiotics, corticoids or probiotics in the previous month.
The study team makes the final eligibility decision.
Where it's taking place
- Milan, Lombardy, Italy
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 15 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 3 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Milan, Lombardy, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.